Kohno S et al. |
Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma. |
2006 |
Biomed. Pharmacother. |
pmid:16337105
|
Eucker J et al. |
Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. |
2006 |
Anticancer Drugs |
pmid:16926626
|
Willermain F et al. |
15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism. |
2006 |
Prostaglandins Other Lipid Mediat. |
pmid:16939878
|
Lim HJ et al. |
PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs. |
2006 |
Prostaglandins Other Lipid Mediat. |
pmid:16939881
|
Calabrò P et al. |
Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. |
2005 Nov-Dec |
J. Vasc. Res. |
pmid:16155367
|
Marchini C et al. |
Aspirin modulates LPS-induced nitric oxide release in rat glial cells. |
2005 Jun 10-17 |
Neurosci. Lett. |
pmid:15882795
|
Yuan J et al. |
Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma. |
2005 |
Urology |
pmid:15780399
|
Unno Y et al. |
Glycolaldehyde-modified bovine serum albumin downregulates leptin expression in mouse adipocytes via a CD36-mediated pathway. |
2005 |
Ann. N. Y. Acad. Sci. |
pmid:16037295
|
Marshall JC |
Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? |
2005 |
Intensive Care Med |
pmid:15782317
|
Usui S et al. |
Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:15745794
|
Storer PD et al. |
Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. |
2005 |
J. Neuroimmunol. |
pmid:15748950
|
Mochizuki M et al. |
Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. |
2005 |
Am. J. Respir. Crit. Care Med. |
pmid:15750045
|
Artwohl M et al. |
Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism. |
2005 |
Diabetologia |
pmid:15729575
|
Moulin D et al. |
Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15751073
|
Viñals M et al. |
Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. |
2005 |
Cardiovasc. Res. |
pmid:15769457
|
Tsao WC et al. |
Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway. |
2005 |
Exp. Cell Res. |
pmid:15707588
|
Yuan Z et al. |
Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. |
2005 |
Heart |
pmid:15774612
|
Han S et al. |
Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. |
2005 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:15908479
|
Hwang J et al. |
Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. |
2005 |
Am. J. Physiol., Cell Physiol. |
pmid:15590897
|
Farrajota K et al. |
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15641079
|
Nakanishi T et al. |
Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions. |
2005 |
Mol. Endocrinol. |
pmid:15941851
|
Coyle AT et al. |
15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. |
2005 |
FEBS J. |
pmid:16156795
|
O'Flaherty JT et al. |
5-Oxo-ETE analogs and the proliferation of cancer cells. |
2005 |
Biochim. Biophys. Acta |
pmid:16154383
|
Koh SH et al. |
15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant? |
2005 |
Toxicology |
pmid:16191461
|
Gayarre J et al. |
Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. |
2005 |
FEBS Lett. |
pmid:16223487
|
Nie M et al. |
Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. |
2005 |
J. Biol. Chem. |
pmid:15531761
|
Kobayashi Y et al. |
Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation. |
2005 |
J. Immunol. |
pmid:16237065
|
Thomas RK et al. |
Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. |
2005 |
Clin. Cancer Res. |
pmid:16299251
|
Piva R et al. |
15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. |
2005 |
Blood |
pmid:15498850
|
Muñoz U et al. |
The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients. |
2005 |
Exp. Neurol. |
pmid:16061222
|
Kim KA et al. |
15d-Deoxy-Delta12,14-prostaglandin J2 modulates collagen type I synthesis in human hepatic stellate cells by inducing oxidative stress. |
2005 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:16098720
|
MartÃnez B et al. |
The mitochondrial respiratory complex I is a target for 15-deoxy-delta12,14-prostaglandin J2 action. |
2005 |
J. Lipid Res. |
pmid:15654126
|
Liang X et al. |
Prostaglandin D2 mediates neuronal protection via the DP1 receptor. |
2005 |
J. Neurochem. |
pmid:15659218
|
Shen ZN et al. |
Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15694358
|
Shiraki T et al. |
Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. |
2005 |
J. Biol. Chem. |
pmid:15695504
|
GarcÃa-Bueno B et al. |
The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. |
2005 |
Psychopharmacology (Berl.) |
pmid:15719215
|
Storer PD et al. |
Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. |
2005 |
J. Neurosci. Res. |
pmid:15723383
|
Migita H and Morser J |
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15662020
|
Tanaka T et al. |
Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. |
2005 |
Eur. J. Pharmacol. |
pmid:15680279
|
Genovese T et al. |
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. |
2005 |
Eur. Respir. J. |
pmid:15684285
|
Kim HJ et al. |
15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes. |
2005 |
Exp. Mol. Med. |
pmid:16000871
|
Pande V and Ramos MJ |
Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:16006125
|
Eggler AL et al. |
Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16006525
|
Matsuzaki Y et al. |
15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. |
2005 |
Int. J. Oncol. |
pmid:16010433
|
Urahama N et al. |
The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation. |
2005 |
Genes Cells |
pmid:16324150
|
Imaizumi T et al. |
Effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of retinoic acid-inducible gene-I in endothelial cells stimulated with lipopolysaccharide. |
2005 |
Prostaglandins Other Lipid Mediat. |
pmid:16303604
|
Burgess HA et al. |
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. |
2005 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:15734787
|
Inoue K et al. |
Effects of 15-deoxy-Delta12,14-prostaglandin J2 on the expression of Toll-like receptor 4 and 2 in the murine lung in the presence of lipopolysaccharide. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:15743408
|
Lindström TM and Bennett PR |
15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. |
2005 |
J. Clin. Endocrinol. Metab. |
pmid:15755849
|
Takashima T et al. |
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. |
2005 |
Oncol. Rep. |
pmid:15756430
|